PortfoliosLab logoPortfoliosLab logo
ISIN
US2289031005
CUSIP
228903100
IPO Date
Feb 12, 1993

Highlights

Market Cap
$1.02B
Enterprise Value
$981.80M
EPS (TTM)
$0.24
PE Ratio
85.16
PEG Ratio
0.88
Total Revenue (TTM)
$458.69M
Gross Profit (TTM)
$292.61M
EBITDA (TTM)
$53.91M
Year Range
$19.16 - $48.25
Target Price
$53.00
ROA (TTM)
1.32%
ROE (TTM)
2.60%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Artivion, Inc.

Performance

AORT Performance Chart

Artivion, Inc. (AORT) is down 54.9% since the beginning of the year. At $21 per share, AORT is trading 57.3% below its 52-week high of $48. Investors who bought $1,000 worth of AORT shares 5 years ago would now be looking at an investment worth $712.


Loading charts...

S&P 500 Index

Returns By Period

Artivion, Inc. (AORT) has returned -54.88% so far this year and -27.66% over the past 12 months. Over the last ten years, AORT has returned 5.73% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.


Artivion, Inc.

1D
0.78%
1M
-42.08%
YTD
-54.88%
6M
-54.75%
1Y
-27.66%
3Y*
10.41%
5Y*
-6.56%
10Y*
5.73%

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AORT Monthly Returns History

Based on dividend-adjusted daily data since Feb 12, 1993, AORT's average daily return is +0.10%, while the average monthly return is +1.69%. At this rate, an investment would double in approximately 3.4 years.

Historically, 51% of months were positive and 49% were negative. The best month was Oct 2002 with a return of +48.3%, while the worst month was Aug 2002 at -77.7%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.

On a daily basis, AORT closed higher 47% of trading days. The best single day was Sep 6, 2002 with a return of +116.9%, while the worst single day was Aug 15, 2002 at -63.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-10.61%-5.57%-4.88%-2.16%-38.07%-7.26%-54.88%
20258.29%-17.93%-3.27%-3.62%24.86%5.14%-0.61%42.12%-3.62%7.16%2.84%-2.25%59.53%
2024-6.49%15.43%9.64%-7.28%20.29%8.69%5.85%-0.04%-1.92%-1.09%12.12%-3.15%59.90%
20237.59%1.53%-1.06%5.88%8.00%14.75%1.34%-2.87%-10.40%-15.96%39.25%0.79%47.52%
2022-12.53%9.83%9.36%-5.10%-3.60%-3.48%3.81%13.06%-37.55%-19.36%14.61%-5.24%-40.44%
20211.36%5.52%-10.57%29.23%-1.27%-1.42%-4.93%-2.81%-15.05%-7.40%-16.72%18.38%-13.81%

Benchmark Metrics

Artivion, Inc. has an annualized alpha of 15.35%, beta of 1.06, and R2 of 0.09 versus S&P 500 Index. Calculated based on daily prices since February 16, 1993.

  • This stock participated in 108.50% of S&P 500 Index downside but only 91.95% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.09 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
15.35%
Beta
1.06
0.09
Upside Capture
91.95%
Downside Capture
108.50%

Return for Risk

Risk / Return Rank

AORT ranks 17 for risk / return — in the bottom 17% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


AORT Risk / Return Rank: 1717
Overall Rank
AORT Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
AORT Sortino Ratio Rank: 2020
Sortino Ratio Rank
AORT Omega Ratio Rank: 1717
Omega Ratio Rank
AORT Calmar Ratio Rank: 2424
Calmar Ratio Rank
AORT Martin Ratio Rank: 66
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Artivion, Inc. (AORT) and compare them to S&P 500 Index.


AORTBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.54

2.24

-2.78

Sortino ratio

Return per unit of downside risk

-0.49

3.07

-3.56

Omega ratio

Gain probability vs. loss probability

0.92

1.41

-0.49

Calmar ratio

Return relative to maximum drawdown

-0.49

2.93

-3.41

Martin ratio

Return relative to average drawdown

-1.48

13.52

-15.00

Dividends

Dividend History

Artivion, Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%0.20%0.40%0.60%0.80%1.00%1.20%$0.00$0.02$0.04$0.06$0.08$0.10$0.1220152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.12

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.11%

Monthly Dividends

The table displays the monthly dividend distributions for Artivion, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Artivion, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Artivion, Inc. was 95.72%, occurring on Sep 5, 2002. Recovery took 5769 trading sessions.

The current Artivion, Inc. drawdown is 56.79%.


Related event

Drawdown

Fall

Recovery

Underwater

Dot-com crash2000–2002
-95.72%Sep 2002
1y 1mo22y 11mo
24y 14dAug 2001 - Aug 2025
1997 bear market1997
-60.74%Apr 1997
10mo 15d2y 11mo
3y 9moMay 1996 - Mar 2000
1994 bear market1994
-58.33%Apr 1994
1y 1mo1y 3mo
2y 4moFeb 1993 - Jul 1995
2026 bear market2026
-57.13%Jun 2026
6mo 21d
6mo 23dNov 2025 - now
Dot-com crash2000–2002
-43.27%Mar 2001
3mo 4d3mo 5d
6mo 9dDec 2000 - Jun 2001

Drawdown Indicators


AORTBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-95.72%

-56.78%

-38.94%

Max Drawdown (1Y)

Largest decline over 1 year

-57.13%

-9.10%

-48.03%

Max Drawdown (3Y)

Largest decline over 3 years

-57.13%

-18.90%

-38.23%

Max Drawdown (5Y)

Largest decline over 5 years

-66.35%

-25.43%

-40.92%

Max Drawdown (10Y)

Largest decline over 10 years

-72.00%

-33.92%

-38.08%

Current Drawdown

Current decline from peak

-56.79%

-0.74%

-56.05%

Average Drawdown

Average peak-to-trough decline

-56.64%

-10.72%

-45.92%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.76%

1.97%

+16.79%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Artivion, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Artivion, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for AORT, comparing it with other companies in the Medical Devices industry. Currently, AORT has a P/E ratio of 85.2. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for AORT compared to other companies in the Medical Devices industry. AORT currently has a PEG ratio of 0.9. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AORT relative to other companies in the Medical Devices industry. Currently, AORT has a P/S ratio of 2.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for AORT in comparison with other companies in the Medical Devices industry. Currently, AORT has a P/B value of 2.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with AORT

Add Artivion, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with AORT